Showing results (671-680 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|June 23, 2020
Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability StudyChaoying Hu, Bingxin Ji, Xiao Hu, et al.
Clinical Pharmacology in Drug Development|June 23, 2020
Effects of Oxycodone Combined With Flurbiprofen Axetil on Postoperative Analgesia and Immune Function in Patients Undergoing Radical Resection of Colorectal CancerZhengzuo Wan, Chunhua Chu, Rong Zhou, et al.
Clinical Pharmacology in Drug Development|September 16, 2021
Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH1-24 Depot and Methylprednisolone in Healthy SubjectsNagaraju Poola, Bryan Due, Dale Wright, et al.
Clinical Pharmacology in Drug Development|August 30, 2025
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double-Blind, Placebo-Controlled StudyJonathan Williams, Rosa Chan, Chad Orevillo, et al.
Clinical Pharmacology in Drug Development|September 3, 2025
Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160-mg Tablet: Results From 2 Phase 1 Studies in Healthy VolunteersBilal Tariq, Chester Lin, Vaibhav Mundra, et al.
Clinical Pharmacology in Drug Development|May 29, 2020
A Randomized, Double-Blind, Parallel-Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male SubjectsGuoying Cao, Jicheng Yu, Jufang Wu, et al.
Clinical Pharmacology in Drug Development|February 15, 2023
Pharmacokinetics of AXA1665, a Novel Composition of Amino Acids, in Comparison With Protein Supplement: A Single-Dose, Open-Label, Randomized Study in Healthy SubjectsSoniya Vaidya, Joshua McLinden, Paul Hinderliter, et al.
Clinical Pharmacology in Drug Development|December 30, 2016
Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor-Like 1 (ORL-1) Partial Agonist, in Patients With Isolated Systolic HypertensionIlkka Kantola, Mika Scheinin, Trygve Gulbrandsen, et al.
Clinical Pharmacology in Drug Development|March 17, 2017
Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference ProductPetro E Petrides, Christian Schoergenhofer, Rudolf Widmann, et al.
Clinical Pharmacology in Drug Development|March 25, 2017
Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White SubjectsMaiko Nomoto, Gina Pastino, Bhaskar Rege, et al.
Pageof 136